Neuroscience

Overlooked tau-RNA interaction may play key role in dementia

Sometimes in science, "Eureka!" moments happen with surprisingly little effort. Sometimes they take years or decades to emerge. Such was the case with Brian Kraemer's research team and their recent study of the protein tau ...

Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Neuroscience

Down syndrome, like Alzheimer's, is a double-prion disorder

The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer's disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. ...

Neuroscience

New target for Alzheimer's therapies found

The protein medin is deposited in the blood vessels of the brains of Alzheimer's patients along with the protein amyloid-β. Researchers from DZNE have discovered this so-called co-aggregation. They have now published their ...

Neuroscience

Alzheimer's disease can be diagnosed before symptoms emerge

A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms. It is now also possible to predict who will deteriorate within the next ...

page 7 from 40